Skip to contentU
Ultralife Corp
U
ULBIUltralife Corp Q2 2025 · 10-Q
Revenue$48.56M$48.56M+13.0% vs Q2 2024 Net Income$879.00K$879.00K−70.4% vs Q2 2024 EPS Diluted$5.00$5.00+2,677.8% vs Q2 2024 Gross Profit$11,601,000+0.3% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Ultralife Corp · CIK 875657 · Engraved from SEC EDGAR
Operating Cash Flowderived$5,935,000−33.5% Free Cash Flowderived$4,835,000−43.5% Margins · derivedGross margin23.9%−3.0 pt vs Q2 2024
Operating margin4.6%−4.5 pt vs Q2 2024
Net margin1.8%−5.1 pt vs Q2 2024
ended Jun 30, 2025 · filed Aug 7, 2025 · 38 d after period end